If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXeros Tech Regulatory News (XSG)

Share Price Information for Xeros Tech (XSG)

Share Price is delayed by 15 minutes
Get Live Data
1.70    0.00 (0.00%)
Bid:
1.65
Ask:
1.75
Spread: 0.10 (6.061%)
Market Cap: £14.65m
XSG Live PriceLast checked at - London Stock Exchange

Intraday Xeros Tech Share Chart

Result of General Meeting

28 Dec 2017 13:00

RNS Number : 2044A
Xeros Technology Group plc
28 December 2017
 

28 December 2017

 

Xeros Technology Group plc

Result of General Meeting

 

Xeros Technology Group plc (AIM:XSG), the developer and provider of patented polymer based technologies with multiple commercial applications, confirms that all resolutions were duly passed at the Company's General Meeting held earlier today. Accordingly, the Company is pleased to announce that it has, subject to Admission, successfully raised approximately £25 million. The proceeds will be used to accelerate commercialisation of the Group's portfolio of applications; and for continued investment in polymer science and engineering and the creation of intellectual property in support of commercialisation of applications.

 

The Placing Shares have been issued and allotted, conditional only on Admission to AIM. It is expected that the Placing Shares will be admitted to AIM and that dealings will commence on 29 December 2017. Following the Placing, the Company's Enlarged Share Capital will comprise 99,169,956 Ordinary Shares.

 

No Ordinary Shares are held in treasury. Accordingly, this figure of 99,169,956 Ordinary Shares may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Following Admission, the members of the Concert Party will have the following interests in Ordinary Shares.

 

Ordinary Shares subscribed for under the Placing

Total number of Ordinary Shares following Admission

% of Enlarged Share Capital following Admission

Woodford

2,222,222

25,085,961

25.30%

RisingStars Growth Fund II

0

2,798,999

2.82%

Finance Yorkshire Seedcorn LP

0

2,249,665

2.27%

South Yorkshire Investment Fund

0

1,158,999

1.17%

TOTAL

2,222,222

31,293,624

31.56%

 

Capitalised terms used but not defined in this announcement have the meaning set out in the Circular dated 12 December 2017.

 

Enquiries:

Xeros Technology Group plc

Mark Nichols, Chief Executive Officer

Paul Denney, Chief Financial Officer

Tel: 0114 321 6328

 

Jefferies International Limited (Nominated Adviser and Joint Broker)

Simon Hardy / Will Soutar

Tel: 020 7029 8000

Berenberg (Joint Broker)

Chris Bowman / Ben Wright / Laure Fine

Tel: 020 3207 7800

Instinctif Partners

Adrian Duffield / Helen Tarbet / James Gray

 

Tel: 020 7457 2020

 

Notes to Editors

Xeros Technology Group plc (LN: XSG) is a platform technology company that is reinventing water intensive industrial and consumer processes by reducing water and chemistry usage with its polymer technologies. Its patented technologies have the capacity to provide material economic, operational and sustainability improvements that are unattainable with traditional processes. The Group is currently exploiting its intellectual property in three areas: Cleaning Technologies, Tanning Technologies and Textile Technologies. Xeros has a number of agreements in place with such international organisations as Hilton and Wollsdorf Leder.

 

For more information, please visit - www.xerostech.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ROMFEASUEFWSEDE
Date   Source Headline
1st Jul 20268:00 amRNSBlock Listing Six Monthly Return
10th Jun 20263:11 pmRNSResult of AGM
28th Apr 20267:00 amRNSFull Year Results 2025
21st Apr 20267:00 amRNSNotice of Results and Online Presentation
5th Mar 20267:00 amRNSPurchase Order ahead of European Launch of XF3
11th Feb 202610:39 amRNSHolding(s) in Company
2nd Feb 20267:00 amRNSBoard Change
27th Jan 20267:00 amRNSTrading Update
7th Jan 20262:52 pmRNSTR-1 First Equity
2nd Jan 202611:46 amRNSBlock listing Interim Review
11th Dec 20251:06 pmRNSTR-1 Entrepreneurs Fund
2nd Dec 20254:48 pmRNSTR-1 Lombard Odier
2nd Dec 20252:26 pmRNSTR-1 Dowgate
2nd Dec 202511:10 amRNSTR-1 Maven
28th Nov 202511:02 amRNSResults of General Meeting and Director Dealings
27th Nov 202512:28 pmRNSResult of Follow-on Subscription and TVR
26th Nov 20254:44 pmRNSTR-1 Spreadex
11th Nov 20251:14 pmRNSResult of Retail Offer
7th Nov 202510:15 amRNSResult of Fundraising
7th Nov 20257:00 amRNSRetail Offer
6th Nov 20256:32 pmRNSProposed Fundraise
24th Oct 20253:07 pmRNSBlock listing Interim Review
14th Oct 20255:11 pmRNSTR-1 Maven
10th Oct 20255:20 pmRNSTR-1 Dowgate
9th Oct 20252:05 pmRNSTR-1 Spreadex
9th Oct 202511:04 amRNSTR-1 First Equity
8th Oct 20257:00 amRNSBreakthrough Launch Agreement
1st Oct 20252:08 pmRNS-RInterim Results 2025 Online Presentation
30th Sep 20257:00 amRNSInterim Results 2025
15th Sep 20256:07 pmRNSTR-1 Dowgate
12th Sep 20251:03 pmRNSTR-1 Dowgate
5th Aug 202512:13 pmRNSTR-1 First Equity
7th Jul 20252:33 pmRNSTR-1 Spreadex
19th Jun 20251:46 pmRNSResult of AGM
5th Jun 202510:11 amRNSCorrection - Application for Block Listing
4th Jun 202510:00 amRNSApplication for Block Listing
29th May 20252:43 pmRNSTR-1 Spreadex
28th May 20253:32 pmRNSTR-1 First Equity
28th May 20252:31 pmRNSTR-1 Spreadex
27th May 20252:37 pmRNSNotice of AGM and Posting of Annual Report
20th May 20257:00 amRNSFull Year Results 2024 and Trading Update
9th May 202511:08 amRNSTR-1 Spreadex
7th May 20257:00 amRNSNotice of Results and Online Presentation
6th May 202510:10 amRNSTR-1 Maven Capital
2nd May 20254:00 pmRNSTR-1 Spreadex
1st May 20254:35 pmRNSTR-1 - First Equity
31st Mar 20257:00 amRNSGrant of Options
7th Mar 202512:56 pmRNSTR-1 Spreadex
17th Feb 20252:18 pmRNSTR-1 Spreadex
17th Feb 202511:07 amRNSTR-1 First Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.